Agenus Inc (AGEN)
followers
·
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | Garo H. Armen |
Employees: | 440 |
Web site: | agenusbio.com |
3 FORBES ROAD, LEXINGTON, MA, 02421
781-674-4410
|
-
Formally known as:
- Antigenics Inc
Date | Ratio |
---|---|
2011-10-03 | 1:6 |
2023-04-26 | 1019:1000 |
2024-04-12 | 1:20 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Agenus Inc. discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer.
Please log in first to see chart